2016年癌症化疗期间肾损伤的治疗指南 - Suppr

Guidelines for treatment of renal injury during cancer chemotherapy 2016.

作者信息

Horie Shigeo, Oya Mototsugu, Nangaku Masaomi, Yasuda Yoshinari, Komatsu Yasuhiro, Yanagita Motoko, Kitagawa Yuko, Kuwano Hiroyuki, Nishiyama Hiroyuki, Ishioka Chikashi, Takaishi Hiromasa, Shimodaira Hideki, Mogi Akira, Ando Yuichi, Matsumoto Koji, Kadowaki Daisuke, Muto Satoru

机构信息

Department of Urology, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.

Department of Advanced Informatics for Genetic Disease, Juntendo University Graduate School of Medicine, Tokyo, Japan.

出版信息

Clin Exp Nephrol. 2018 Feb;22(1):210-244. doi: 10.1007/s10157-017-1448-z.

DOI:10.1007/s10157-017-1448-z

PMID:28856465

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5805816/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e403/5805816/8493eb3adf2c/10157_2017_1448_Fig1_HTML.jpg

相似文献

Guidelines for treatment of renal injury during cancer chemotherapy 2016.

Clin Exp Nephrol. 2018 Feb;22(1):210-244. doi: 10.1007/s10157-017-1448-z.

Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Clin Exp Nephrol. 2020 Jan;24(1):1-44. doi: 10.1007/s10157-019-01750-5.

Points to remember: practical clinical pearls for the practicing clinician.

Methodist Debakey Cardiovasc J. 2013 Jan-Mar;9(1):60. doi: 10.14797/mdcj-9-1-60.

Evaluation of Longitudinal Exposure to Tacrolimus as a Risk Factor of Chronic Kidney Disease Occurrence Within the First-year Post-Liver Transplantation.

Transplantation. 2021 Jul 1;105(7):1585-1594. doi: 10.1097/TP.0000000000003384.

The Bermuda triangle: Chronic kidney disease, contrast-induced nephropathy, and atrial fibrillation.

Cardiovasc Revasc Med. 2018 Jan;19(1 Pt A):72-74. doi: 10.1016/j.carrev.2017.08.015. Epub 2017 Sep 1.

PPIs and kidney disease: from AIN to CKD.

J Nephrol. 2016 Oct;29(5):611-6. doi: 10.1007/s40620-016-0309-2. Epub 2016 Apr 12.

Elevation of urinary liver-type fatty acid-binding protein as predicting factor for occurrence of contrast-induced acute kidney injury and its reduction by hemodiafiltration with blood suction from right atrium.

Heart Vessels. 2014 Mar;29(2):191-7. doi: 10.1007/s00380-013-0347-9. Epub 2013 Apr 20.

Essentials from clinical practice guidelines for CKD stage G3b-5 2017.

Clin Exp Nephrol. 2018 Apr;22(2):245-248. doi: 10.1007/s10157-018-1532-z. Epub 2018 Feb 1.

Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Kidney Int. 2018 Jun;93(6):1281-1292. doi: 10.1016/j.kint.2018.02.006. Epub 2018 Apr 12.

Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology.

J Nephrol. 2017 Apr;30(2):159-170. doi: 10.1007/s40620-016-0338-x. Epub 2016 Aug 27.

引用本文的文献

Complete Protocol Administration Reduces Local Recurrence and Residual Tumor in Superselective Intra-arterial Cisplatin Infusion and Concomitant Radiotherapy for Maxillary Sinus Cancer.

Interv Radiol (Higashimatsuyama). 2025 Jun 13;10:e20240031. doi: 10.22575/interventionalradiology.2024-0031. eCollection 2025.

Rhein Alleviates Cisplatin-Induced Acute Kidney Injury via Downregulation of NOX4-COX2/PGFS Signaling Pathway.

Drug Des Devel Ther. 2025 May 31;19:4641-4664. doi: 10.2147/DDDT.S515409. eCollection 2025.

Aligning kidney function assessment in patients with cancer to global practices in internal medicine.

EClinicalMedicine. 2025 Mar 25;82:103102. doi: 10.1016/j.eclinm.2025.103102. eCollection 2025 Apr.

Nephrol Dial Transplant. 2025 Mar 13;40(Supplement_2):ii54-ii63. doi: 10.1093/ndt/gfae249.

Transarterial Chemoembolization for Patients With Hepatocellular Carcinoma Using Miriplatin Without the Need for Hydration.

Clin Transl Sci. 2025 Mar;18(3):e70182. doi: 10.1111/cts.70182.

Optimization of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy for Japanese patients with urothelial carcinoma.

Jpn J Clin Oncol. 2025 Apr 6;55(4):421-427. doi: 10.1093/jjco/hyaf001.

Evaluation of urinary vanin-1 for the early prediction of cisplatin-induced acute kidney injury during neoadjuvant chemotherapy for esophageal cancer.

Cancer Chemother Pharmacol. 2024 Dec 23;95(1):11. doi: 10.1007/s00280-024-04737-6.

Platinum-based chemotherapies-induced nephrotoxicity: mechanisms, potential treatments, and management.

Int Urol Nephrol. 2025 May;57(5):1563-1583. doi: 10.1007/s11255-024-04303-2. Epub 2024 Dec 4.

Effective treatment of collecting duct carcinoma in a recipient of a kidney transplant: A case report.

Oncol Lett. 2024 Sep 3;28(5):528. doi: 10.3892/ol.2024.14661. eCollection 2024 Nov.

Complex Interplay between DNA Damage and Autophagy in Disease and Therapy.

Biomolecules. 2024 Jul 29;14(8):922. doi: 10.3390/biom14080922.

本文引用的文献

Increased Plasma Concentrations of Unbound SN-38, the Active Metabolite of Irinotecan, in Cancer Patients with Severe Renal Failure.

Pharm Res. 2016 Feb;33(2):269-82. doi: 10.1007/s11095-015-1785-0. Epub 2015 Sep 3.

Renal function evaluation in patients with cancer who were scheduled to receive carboplatin or S-1.

Clin Exp Nephrol. 2015 Dec;19(6):1107-13. doi: 10.1007/s10157-015-1115-1. Epub 2015 Apr 19.

Estimating GFR in adult patients with hematopoietic cell transplant: comparison of estimating equations with an iohexol reference standard.

Clin J Am Soc Nephrol. 2015 Apr 7;10(4):601-10. doi: 10.2215/CJN.06470614. Epub 2015 Feb 25.

New drug toxicities in the onco-nephrology world.

Kidney Int. 2015 May;87(5):909-17. doi: 10.1038/ki.2015.30. Epub 2015 Feb 11.

Proteinuria with first-line therapy of metastatic renal cell cancer.

J Oncol Pharm Pract. 2016 Apr;22(2):235-41. doi: 10.1177/1078155214563153. Epub 2014 Dec 9.

[Drug/transplant-induced atypical hemolytic uremic syndrome].

Nihon Jinzo Gakkai Shi. 2014;56(7):1067-74.

Evaluation of the cisplatin nephrotoxicity using the urinary neutrophil gelatinase-associated lipocalin (NGAL) in patients with head and neck cancer.

J Bras Nefrol. 2014 Jul-Sep;36(3):280-8. doi: 10.5935/0101-2800.20140041.

Is the eGFR formula adequate for evaluating renal function before chemotherapy in patients with urogenital cancer? A suggestion for clinical application of eGFR formula.

Clin Exp Nephrol. 2015 Aug;19(4):738-45. doi: 10.1007/s10157-014-1037-3. Epub 2014 Oct 4.

Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.

Cochrane Database Syst Rev. 2014 Aug 14(8):CD006945. doi: 10.1002/14651858.CD006945.pub3.

Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):147-55. doi: 10.2215/CJN.12191213. Epub 2014 Aug 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Guidelines for treatment of renal injury during cancer chemotherapy 2016.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Guidelines for treatment of renal injury during cancer chemotherapy 2016.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献